
Benzinga Pro data, HOOKIPA Pharma (NASDAQ:HOOK) reported Q4 sales of $3.90 million. Earnings fell to a loss of $21.23 million, resulting in a 5.96% decrease from last quarter. HOOKIPA Pharma collected $3.87 million in revenue during Q3, but reported earnings showed a $20.04 million loss.